换一批
换一批SurvivinT34A increases the therapeutic efficacy of arsenic trioxide in mouse hepatocellular carcinoma models.
作者：
主题词
动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞凋亡(Apoptosis);砷剂(Arsenicals);癌, 肝细胞(Carcinoma, Hepatocellular);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);凋亡抑制蛋白质类(Inhibitor of Apoptosis Proteins);脂质体(Liposomes);肝肿瘤, 实验性(Liver Neoplasms, Experimental);膜电位, 线粒体(Membrane Potential, Mitochondrial);小鼠, 近交C57BL(Mice, Inbred C57BL);突变, 误义(Mutation, Missense);肿瘤移植(Neoplasm Transplantation);氧化物(Oxides);活性氧(Reactive Oxygen Species);阻遏蛋白质类(Repressor Proteins)
DOI
10.3892/or.2016.5161
PMID
27748945
发布时间
2018-12-02
- 浏览20
Oncology reports
3283-3290页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
